MDA 19 is a selective human peripheral cannabinoid CB2 receptor agonist. MDA 19 displays 4-fold higher affinity for the human CB2 receptor than the human CB1 receptor (Ki values are 43.3 and 162.4 nM respectively); MDA 19 shows 70-fold affinity for the rat CB2 receptor over the rat CB1 receptor (Ki values are 16.3 and 1130 nM respectively). MDA 19 attenuates tactile allodynia in a rat model. MDA 19 does not affect rat locomotor activity.
Citations
No citations are currently available for this product. Below are selected publications citing GlpBio products.Description
Product Documents
Purity:>95.00%Appearance:A solid
Chemical Properties
CAS No.
1048973-47-2
Synonyms
BZO-HEXOXIZID
Chemical Name
N-[(Z)-(1-hexyl-2-oxoindol-3-ylidene)amino]benzamide
SMILES
CCCCCCN1C2=CC=CC=C2C(=NNC(=O)C3=CC=CC=C3)C1=O
Molecular Formula
C21H23N3O2
Molecular Weight
349.43
Solubility
DMF: 20 mg/ml,DMSO: 10 mg/ml,Ethanol: 3 mg/ml
Storage
Store at -20°C
General tips
Select a suitable solvent according to the product solubility data. Once prepared, aliquot the stock solution to avoid repeated freeze-thaw cycles.
Use stock solutions within 6 months when stored at -80°C or within 1 month when stored at -20°C.
To improve solubility, warm the tube to 37°C and sonicate it for an appropriate period.
Use stock solutions within 6 months when stored at -80°C or within 1 month when stored at -20°C.
To improve solubility, warm the tube to 37°C and sonicate it for an appropriate period.
Shipping Condition
Evaluation samples are shipped with blue ice. Other available sizes are shipped at room temperature or with blue ice upon request.
CalculatorsMolarity / Dilution / Molecular Weight / Unit Conversion / In Vivo Formulation / Solubility
g/mol
Reviews
Review for MDA 19
Rating: 5
- 5 Star100%
- 4 Star0%
- 3 Star0%
- 2 Star0%
- 1 Star0%
















